Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
632 A phase 1/2 open label study of LabVax 3(22)-23 and adjuvant GM-CSF alone or in combination with pembrolizumab in subjects with labyrinthin-positive adenocarcinomasLi, Tianhong ; Chen, Shuai ; Ma, Weijie ; Toomey, Kyra A ; Long, Siqi ; Lu, Tingting ; Pineda, Colleen ; Molnar, Laura ; Garcia, Leslie ; Tam, Kit ; Verma, Rashmi ; Zhou, Chihong ; Ogilhara, Nancy ; Babich, MichaelJournal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A722-A722 [Periódico revisado por pares]London: BMJ Publishing Group LtdTexto completo disponível |